Skip to main content

Table 1 qPCR validation for immunoregulatory/neuroprotective genes

From: Polarizing receptor activation dissociates fibroblast growth factor 2 mediated inhibition of myelination from its neuroprotective potential

Gene

qPCR validation

fold change (p-value versus control)

Microarray

fold change

Primer sequence

FGF2

F2 V2

FGF2

F2 V2

Cd93

240.2 ± 101.2 (***)

44.9 ± 9.1 (***)

74.1

23.8

CATCTCACTCTTGCTGGCTCT TCTCCTCTTTCTTGGCTTTCC

Il11

48.4 ± 19.8 (***)

14.9 ± 3.7 (**)

47.5

6.3

CTCCCCTCGAGTGTCTTCAG CCATCAGCTGGGAATTTGTC

Hb-egf

22.2 ± 12.0 (***)

7.1 ± 2.5 (**)

11.9

4.9

TTTCTCCTCCAAGCCACAAG TTCCTCTTCTTTTTCCCGTTC

Lif

13.6 ± 4.6 (***)

3.8 ± 1.7 (*)

19.4

4.0

CCTTCCCATCACCCCTGT CGTTGAGTTGAGCCAGTTGA

Cxcl1

12.5 ± 4.1 (***)

8.4 ± 1.8 (***)

4.0

5.6

AACCGAAGTCATAGCCACACTC CACCCTTTAGCATCTTTTGGAC

Timp1

6.2 ± 0.9 (**)

5.8 ± 1.8 (**)

2.8

2.3

CTGGTTCCCTGGCATAATCT ATCGCTCTGGTAGCCCTTCT

Mmp13

28.6 ± 14.0 (***)

2.2 ± 1.8 (ns)

28.1

1.2

CTGCGGTTCACTTTGAGGA GAGGCGGGGATAGTCTTTGT

Mmp3

8.1 ± 3.5 (*)

0.4 ± 1.2 (ns)

6.8

−1.0

CCCGTTTCCATCTCTCTCAA GACATCAGGGGATTCTGTGG

  1. Shown are mean +/− SEM of at least 5 independent experiments; p-values for ΔCt of Control vs FGF2 or F2 V2 respectively (one-way ANOVA, Holm-Sidak post-test); * p < 0.05, ** p < 0.01, *** p < 0.001, ns - not significant